Heme Oxygenase-1 Protects Human Hepatocytes in Vitro Against Warm and Cold Hypoxia

E Tuzuner,LG Liu,M Shimada,E Yilmaz,M Glanemann,U Settmacher,JM Langrehr,S Jonas,P Neuhaus,AK Nussler
DOI: https://doi.org/10.1016/j.jhep.2004.07.013
IF: 25.7
2004-01-01
Journal of Hepatology
Abstract:Background/Aims: Hepatic injury induced by ischemia/reperfusion following surgery, transplantation, or circulatory shock combined with resuscitation is a major clinical problem.Methods: In this study, hypoxic and inflammatory conditions were mimicked by exposing human hepatocytes to N-2 (at 4 and 37degreesC or to cytokines/endotoxin to investigate the potential protective effects of heme oxygenase-1 (HO-1). Incubation of human hepatocytes with single cytokines (IFN-gamma, IL-1beta, TNF-alpha) or LPS, as well as a combination of all four stimuli (CM, cytomix) caused a time-dependent HO-1 mRNA expression over 12 h and a decline by 24 h. In parallel, we observed a time-dependent membrane leakage for LDH and AST and a maximum HO-1 protein expression between 3-24 h.Results: Warm and cold hypoxia showed similar results in HO-1 mRNA and protein expression and the release of LDH and AST. CoPP, a potent HO-1 inducer, and bilirubin, a co-product of the HO-pathway, protected human hepatocytes from warm and cold hypoxia. HO-1 enzyme activity was highest during warm hypoxia, followed by cold hypoxia and CM which was confirmed by intracellular Fe2+ formation.Conclusions: Taken together, we demonstrated, that HO-I induction protected human hepatocytes against warm and cold hypoxia. Our results also suggest that HO-1 induction may have therapeutic potential against inflammatory insults. (C) 2004 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
What problem does this paper attempt to address?